2002
Functional genomics and the breast cancer problem. Cancer Cell. 2002;1(1):15-7.
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization. Am J Pathol. 2002;161(4):1349-55.
Integrating cancer genomics and proteomics in the post-genome era. Proteomics. 2002;2(1):69-75.
OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.
Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74(9):1273-80.
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002;21(7):1038-47.
Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microsc Res Tech. 2002;59(2):85-91.
CD2 is a dominant target for allogeneic responses. Am J Transplant. 2002;2(7):618-26.
Practical considerations in the pathologic diagnosis of needle core biopsies of breast. Am J Clin Pathol. 2002;118(1):101-8.